Research
Hormonal
In randomized controlled trials, GLP-1RAs induce a weight reduction of 4.36 kg compared to placebo.
GLP-1RAs can be beneficial for weight loss in a controlled setting post-bariatric surgery.
StrongSupportsmedium confidence
Data from RCTs showed that the use of GLP-1RAs induced weight reduction of 4.36 kg compared to placebo.
Why this rating
Based on a systematic review and meta-analysis of 17 studies.
Source
Effect of Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) on Weight Loss Following Bariatric Treatment
Caroline K. Kramer et al. · The Journal of Clinical Endocrinology & Metabolism · 2024
Meta-analysisCited 23×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →